The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa.
Africa
Coronavirus
Facebook
Healthcare workers
Lockdown
Media
Misinformation
Radio
Survey
Television
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
06 01 2023
06 01 2023
Historique:
received:
22
02
2022
accepted:
29
12
2022
entrez:
7
1
2023
pubmed:
8
1
2023
medline:
11
1
2023
Statut:
epublish
Résumé
Vaccination remains the most powerful weapon against the emergence of new variants of coronavirus (COVID-19). However, false information about COVID-19 vaccines through various platforms including social media remains a major threat to global public health. This study examined the impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa (SSA). A validated web-based cross-sectional study was conducted from 14 March to 16 May 2021, and was administered in both French and English to 2572 participants aged 18 years and over. Data on sociodemographic characteristics, medical and vaccination history, and the information sources (mainstream media and social media) used by the participants during the pandemic were obtained. There were three main outcomes: The vaccinated group were those who responded in the affirmation (Yes) to the question of whether they have been vaccinated against COVID-19. Those who responded 'not sure' or 'no' to the question were then asked if they were willing to be vaccinated when the vaccine became available in their home countries. The responses to this follow-up question were used to derive the second and third outcome variables of 'vaccine hesitancy' and 'vaccine resistance', respectively. A series of logistic regression analyses were used to examine the impact of information sources on the three main outcomes. The prevalence of COVID-19 vaccine hesitancy among the participants was lowest among newspaper readers (42%) and highest among TV (72%) and social media users (73%). The prevalence of COVID-19 vaccine-resistance was also lowest among newspaper readers (37%) but highest among social media users (87%). Multivariate analyses revealed that compared to those who did not use these information sources, SSA participants who relied on the radio (aOR 0.83, 95%CI = 0.70, 0.99), TV (aOR 0.80, 95%CI = 0.65, 0.97) and social media (aOR 0.79, 95%CI = 0.65, 0.97) for information during the pandemic were less likely to be hesitant towards taking the vaccines. However, social media users (aOR 2.13, 95%CI = 1.62, 2.80), those who watched TV (aOR 1.40, 95%CI =1.08, 1.80), relied on healthcare workers (HCWs: aOR 1.32, 95%CI = 1.07, 1.63) and families/friends (aOR 1.31, 95%CI = 1.06, 1.61) for COVID-19 related information during the pandemic were more likely to resist taking the COVID vaccines in this study. Participants who relied on the newspaper for information during the pandemic were less likely to resist the vaccines (aOR 0.77, 95%CI = 0.62, 0.95) compared to non-readers of a newspaper. We found that all six information sources except radio were strong predictors of the resistance towards COVID-19 vaccination. Further research on how these channels can be used to improve the availability of reliable healthcare information is needed. Investments in these resources will protect people and empower them to make appropriate choices about their health.
Sections du résumé
BACKGROUND
Vaccination remains the most powerful weapon against the emergence of new variants of coronavirus (COVID-19). However, false information about COVID-19 vaccines through various platforms including social media remains a major threat to global public health. This study examined the impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa (SSA).
METHODS
A validated web-based cross-sectional study was conducted from 14 March to 16 May 2021, and was administered in both French and English to 2572 participants aged 18 years and over. Data on sociodemographic characteristics, medical and vaccination history, and the information sources (mainstream media and social media) used by the participants during the pandemic were obtained. There were three main outcomes: The vaccinated group were those who responded in the affirmation (Yes) to the question of whether they have been vaccinated against COVID-19. Those who responded 'not sure' or 'no' to the question were then asked if they were willing to be vaccinated when the vaccine became available in their home countries. The responses to this follow-up question were used to derive the second and third outcome variables of 'vaccine hesitancy' and 'vaccine resistance', respectively. A series of logistic regression analyses were used to examine the impact of information sources on the three main outcomes.
RESULTS
The prevalence of COVID-19 vaccine hesitancy among the participants was lowest among newspaper readers (42%) and highest among TV (72%) and social media users (73%). The prevalence of COVID-19 vaccine-resistance was also lowest among newspaper readers (37%) but highest among social media users (87%). Multivariate analyses revealed that compared to those who did not use these information sources, SSA participants who relied on the radio (aOR 0.83, 95%CI = 0.70, 0.99), TV (aOR 0.80, 95%CI = 0.65, 0.97) and social media (aOR 0.79, 95%CI = 0.65, 0.97) for information during the pandemic were less likely to be hesitant towards taking the vaccines. However, social media users (aOR 2.13, 95%CI = 1.62, 2.80), those who watched TV (aOR 1.40, 95%CI =1.08, 1.80), relied on healthcare workers (HCWs: aOR 1.32, 95%CI = 1.07, 1.63) and families/friends (aOR 1.31, 95%CI = 1.06, 1.61) for COVID-19 related information during the pandemic were more likely to resist taking the COVID vaccines in this study. Participants who relied on the newspaper for information during the pandemic were less likely to resist the vaccines (aOR 0.77, 95%CI = 0.62, 0.95) compared to non-readers of a newspaper.
CONCLUSION
We found that all six information sources except radio were strong predictors of the resistance towards COVID-19 vaccination. Further research on how these channels can be used to improve the availability of reliable healthcare information is needed. Investments in these resources will protect people and empower them to make appropriate choices about their health.
Identifiants
pubmed: 36609264
doi: 10.1186/s12889-022-14972-2
pii: 10.1186/s12889-022-14972-2
pmc: PMC9816548
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2021 May 12;16(5):e0251095
pubmed: 33979370
J Med Virol. 2022 Jan;94(1):11-13
pubmed: 34403149
BMC Public Health. 2022 Feb 21;22(1):375
pubmed: 35189874
Vaccine. 2015 Aug 14;33(34):4212-4
pubmed: 25896382
BMC Public Health. 2021 Aug 18;21(1):1562
pubmed: 34404377
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
Hum Vaccin Immunother. 2022 Dec 31;18(1):1872340
pubmed: 33596388
BMJ. 2021 Mar 11;372:n699
pubmed: 33707182
Int J Health Plann Manage. 2022 May;37(3):1847-1850
pubmed: 34510541
Pediatrics. 2014 Apr;133(4):e835-42
pubmed: 24590751
Brain Behav Immun. 2021 May;94:41-50
pubmed: 33713824
Acad Pediatr. 2021 May-Jun;21(4S):S32-S33
pubmed: 33958089
Nature. 2020 Apr 14;:
pubmed: 32291410
JAMA Intern Med. 2020 Nov 1;180(11):1453-1459
pubmed: 32749450
PLoS One. 2022 May 18;17(5):e0268711
pubmed: 35584110
Curr Med Res Opin. 2008 Jun;24(6):1719-41
pubmed: 18474148
Epidemiology (Sunnyvale). 2016 Apr;6(2):
pubmed: 27274911
Risk Manag Healthc Policy. 2021 Nov 27;14:4799-4807
pubmed: 34866949
JMIR Public Health Surveill. 2020 Sep 15;6(3):e22060
pubmed: 32930670
J Evid Based Med. 2020 May;13(2):168-172
pubmed: 32445287
Health Secur. 2021 Jan-Feb;19(1):44-56
pubmed: 33606572
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Nat Med. 2021 Sep;27(9):1622-1628
pubmed: 34413518
BMJ Glob Health. 2020 May;5(5):
pubmed: 32409327
Trop Med Health. 2021 Nov 24;49(1):93
pubmed: 34819175
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccines (Basel). 2022 Feb 10;10(2):
pubmed: 35214724
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312
pubmed: 33118868
Afr J Prim Health Care Fam Med. 2021 Jun 15;13(1):e1-e8
pubmed: 34212739
BMJ. 2021 Feb 2;372:n308
pubmed: 33531333
Appl Health Econ Health Policy. 2020 Jun;18(3):325-328
pubmed: 32249362
Prev Med. 2019 Jan;118:251-256
pubmed: 30414396
Lancet Digit Health. 2020 Jun;2(6):e277-e278
pubmed: 32322814
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Vaccines (Basel). 2021 Apr 13;9(4):
pubmed: 33924604
Int J Public Health. 2022 Feb 16;67:1604221
pubmed: 35250430
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100920
pubmed: 34901523
EClinicalMedicine. 2022 Jun 25;50:101499
pubmed: 35770256
PLoS One. 2021 Apr 16;16(4):e0250269
pubmed: 33861811
Ther Adv Vaccines Immunother. 2022 Feb 10;10:25151355221077658
pubmed: 35174312
PLoS One. 2021 Mar 30;16(3):e0249135
pubmed: 33784366
Psychol Res Behav Manag. 2020 Sep 03;13:713-720
pubmed: 32982500
Hum Vaccin Immunother. 2017 Aug 3;13(8):1895-1901
pubmed: 28481675
Trop Med Health. 2021 Dec 29;49(1):101
pubmed: 34963494
Vaccine. 2016 Nov 11;34(47):5808-5814
pubmed: 27707558
Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593
pubmed: 32693678
JMIR Public Health Surveill. 2018 Sep 20;4(3):e10090
pubmed: 30249585
Front Public Health. 2021 Apr 29;9:614858
pubmed: 33996709
BMC Public Health. 2022 Jan 18;22(1):128
pubmed: 35042476
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):32-39
pubmed: 31802154
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
BMJ. 2021 Feb 26;372:n513
pubmed: 33637577
JAMA. 2021 Mar 16;325(11):1101-1102
pubmed: 33576785
Germs. 2017 Dec 5;7(4):168-170
pubmed: 29264353
Vaccine. 2018 Sep 5;36(37):5617-5624
pubmed: 30087047
J Gerontol B Psychol Sci Soc Sci. 2021 Jan 18;76(2):e10-e16
pubmed: 32282920
Infect Dis Rep. 2021 Aug 12;13(3):712-723
pubmed: 34449654
Int J Environ Res Public Health. 2021 Oct 13;18(20):
pubmed: 34682502